Monopar Therapeutics

Monopar Therapeutics

  • Founded: 2014
  • Location: Wilmette, IL
  • Employee range: 11 - 50
  • Clinical stage: Clin2
  • Therapy area: Chemoradiation-induced oral mucositis
  • Drug types: ORL, ONC, INF
  • Lead product: Validive
  • Product link: https://www.monopartx.com/pipeline/pipeline-chart
  • Funding: $9M IPO Dec 2019; $9M Nov 2019


monopartx.com

linkedin.com

job board


Short description:

Small Molecules

Drug notes:

Camsirubicin Clin1b soft tissue sarcoma; MNPR-101 RIT RD/Clin0 solid tumors, RD/Clin0 COVID-19; MNPR-101 RD/Clin0 solid tumors; MNPR-202 RD/Clin0 solid tumors

Long description:

Contact us to add description: recruit@workinbiotech.com

Jobs:


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com